NCT01211327View on ClinicalTrials.gov

Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda

PHASE4CompletedINTERVENTIONAL

Enrollment

366

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Vernal Keratoconjunctivitis

Interventions

DRUG

Cyclosporine A

Cyclosporine 2% eye drops

DRUG

Dexamethasone

Dexamethasone 0,1% eye drops

Trial Locations (1)

Unknown

Kabgayi Hospital, Gitarama/Muhanga

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Funds for Research in Ophthalmology (FRO) of Belgium

UNKNOWN

collaborator

Novartis

INDUSTRY

lead

University Hospital, Ghent

OTHER